# Study of Amifostine and IMRT for Protecting Salivary Glands in Head and Neck Cancer

> **NCT00167908** · PHASE2 · COMPLETED · sponsor: **Washington University School of Medicine** · enrollment: 27 (—)

## Conditions studied

- Head and Neck Cancer

## Interventions

- **DRUG:** Ethyol (drug)

## Key facts

- **NCT ID:** NCT00167908
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-10
- **Primary completion:** —
- **Final completion:** 2007-05
- **Target enrollment:** 27 (—)
- **Last updated:** 2009-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00167908

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00167908, "Study of Amifostine and IMRT for Protecting Salivary Glands in Head and Neck Cancer". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00167908. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*